Literature DB >> 31901293

Dysregulated Fc gamma receptor-mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis.

Young Ho Park1, Angela Hodges2, Shannon L Risacher3, Kuang Lin2, Jae-Won Jang4, Soyeon Ahn5, SangYun Kim6, Simon Lovestone7, Andrew Simmons2, Michael W Weiner8, Andrew J Saykin9, Kwangsik Nho10.   

Abstract

Transcriptomics has become an important tool for identification of biological pathways dysregulated in Alzheimer's disease (AD). We performed a network-based gene expression analysis of blood-based microarray gene expression profiles using 2 independent cohorts, Alzheimer's Disease Neuroimaging Initiative (ADNI; N = 661) and AddNeuroMed (N = 674). Weighted gene coexpression network analysis identified 17 modules from ADNI and 13 from AddNeuroMed. Four of the modules derived in ADNI were significantly related to AD; 5 modules in AddNeuroMed were significant. Gene-set enrichment analysis of the AD-related modules identified and replicated 3 biological pathways including the Fc gamma receptor-mediated phagocytosis pathway. Module-based association analysis showed the AD-related module, which has the 3 pathways, to be associated with cognitive function and neuroimaging biomarkers. Gene-based association analysis identified PRKCD in the Fc gamma receptor-mediated phagocytosis pathway as being significantly associated with cognitive function and cerebrospinal fluid biomarkers. The identification of the Fc gamma receptor-mediated phagocytosis pathway implicates the peripheral innate immune system in the pathophysiology of AD. PRKCD is known to be related to neurodegeneration induced by amyloid-β.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Coexpression; Network; PRKCD; Phagocytosis; Transcriptome

Mesh:

Substances:

Year:  2019        PMID: 31901293      PMCID: PMC7085455          DOI: 10.1016/j.neurobiolaging.2019.12.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  75 in total

1.  Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Paul K Crane; Adam Carle; Laura E Gibbons; Philip Insel; R Scott Mackin; Alden Gross; Richard N Jones; Shubhabrata Mukherjee; S McKay Curtis; Danielle Harvey; Michael Weiner; Dan Mungas
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

Review 2.  Genetics of global gene expression.

Authors:  Matthew V Rockman; Leonid Kruglyak
Journal:  Nat Rev Genet       Date:  2006-11       Impact factor: 53.242

3.  Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease.

Authors:  Bin Zhang; Chris Gaiteri; Liviu-Gabriel Bodea; Zhi Wang; Joshua McElwee; Alexei A Podtelezhnikov; Chunsheng Zhang; Tao Xie; Linh Tran; Radu Dobrin; Eugene Fluder; Bruce Clurman; Stacey Melquist; Manikandan Narayanan; Christine Suver; Hardik Shah; Milind Mahajan; Tammy Gillis; Jayalakshmi Mysore; Marcy E MacDonald; John R Lamb; David A Bennett; Cliona Molony; David J Stone; Vilmundur Gudnason; Amanda J Myers; Eric E Schadt; Harald Neumann; Jun Zhu; Valur Emilsson
Journal:  Cell       Date:  2013-04-25       Impact factor: 41.582

4.  Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease.

Authors:  Kuang-Den Chen; Po-Tsung Chang; Yueh-Hsin Ping; Hsin-Chen Lee; Chin-Wei Yeh; Pei-Ning Wang
Journal:  Neurobiol Dis       Date:  2011-06-06       Impact factor: 5.996

5.  Alzheimer disease biomarkers are associated with body mass index.

Authors:  E D Vidoni; R A Townley; R A Honea; J M Burns
Journal:  Neurology       Date:  2011-11-22       Impact factor: 9.910

6.  Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies.

Authors:  Ka Sing P Lai; Celina S Liu; Allison Rau; Krista L Lanctôt; Cristiano A Köhler; Maureen Pakosh; André F Carvalho; Nathan Herrmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-08-09       Impact factor: 10.154

Review 7.  The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.

Authors:  William J Jagust; Susan M Landau; Robert A Koeppe; Eric M Reiman; Kewei Chen; Chester A Mathis; Julie C Price; Norman L Foster; Angela Y Wang
Journal:  Alzheimers Dement       Date:  2015-07       Impact factor: 21.566

8.  APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.

Authors:  V K Ramanan; S L Risacher; K Nho; S Kim; S Swaminathan; L Shen; T M Foroud; H Hakonarson; M J Huentelman; P S Aisen; R C Petersen; R C Green; C R Jack; R A Koeppe; W J Jagust; M W Weiner; A J Saykin
Journal:  Mol Psychiatry       Date:  2013-02-19       Impact factor: 15.992

9.  KEGG as a reference resource for gene and protein annotation.

Authors:  Minoru Kanehisa; Yoko Sato; Masayuki Kawashima; Miho Furumichi; Mao Tanabe
Journal:  Nucleic Acids Res       Date:  2015-10-17       Impact factor: 16.971

Review 10.  Blood transcriptomics and metabolomics for personalized medicine.

Authors:  Shuzhao Li; Andrei Todor; Ruiyan Luo
Journal:  Comput Struct Biotechnol J       Date:  2015-10-31       Impact factor: 7.271

View more
  9 in total

1.  Deep learning-based identification of genetic variants: application to Alzheimer's disease classification.

Authors:  Taeho Jo; Kwangsik Nho; Paula Bice; Andrew J Saykin
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

2.  Network Biology Approaches to Uncover Therapeutic Targets Associated with Molecular Signaling Pathways from circRNA in Postoperative Cognitive Dysfunction Pathogenesis.

Authors:  Piplu Bhuiyan; G S Chuwdhury; Zhaochu Sun; Yinan Chen; Hongquan Dong; Fee Faysal Ahmed; Li Nana; Md Habibur Rahman; Yanning Qian
Journal:  J Mol Neurosci       Date:  2022-07-06       Impact factor: 2.866

3.  Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease.

Authors:  Young Ho Park; Angela Hodges; Andrew Simmons; Simon Lovestone; Michael W Weiner; SangYun Kim; Andrew J Saykin; Kwangsik Nho
Journal:  Neurol Genet       Date:  2020-09-30

4.  Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer's disease.

Authors:  Young Ho Park; Jung-Min Pyun; Angela Hodges; Jae-Won Jang; Paula J Bice; SangYun Kim; Andrew J Saykin; Kwangsik Nho
Journal:  Alzheimers Res Ther       Date:  2021-11-03       Impact factor: 6.982

5.  Intestinal Flora Balance Therapy Based on Probiotic Support Improves Cognitive Function and Symptoms in Patients with Alzheimer's Disease: A Systematic Review and Meta-analysis.

Authors:  Changxing Liu; Xinyi Guo; Xiang Chang
Journal:  Biomed Res Int       Date:  2022-08-16       Impact factor: 3.246

6.  Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer's disease.

Authors:  Chirag Gupta; Jielin Xu; Ting Jin; Saniya Khullar; Xiaoyu Liu; Sayali Alatkar; Feixiong Cheng; Daifeng Wang
Journal:  PLoS Comput Biol       Date:  2022-07-18       Impact factor: 4.779

7.  Accelerated aging-related transcriptome alterations in neurovascular unit cells in the brain of Alzheimer's disease.

Authors:  Yan Zhao; Yong-Zhi Xie; You-Shuo Liu
Journal:  Front Aging Neurosci       Date:  2022-08-18       Impact factor: 5.702

8.  The plasma peptides of Alzheimer's disease.

Authors:  Angelique Florentinus-Mefailoski; Peter Bowden; Philip Scheltens; Joep Killestein; Charlotte Teunissen; John G Marshall
Journal:  Clin Proteomics       Date:  2021-06-28       Impact factor: 3.988

9.  MicroRNA-Target Interaction Regulatory Network in Alzheimer's Disease.

Authors:  Aleksander Turk; Tanja Kunej; Borut Peterlin
Journal:  J Pers Med       Date:  2021-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.